頁籤選單縮合
題 名 | 第一個針對眼用的Quinolone抗菌劑--Besifloxacin=The First Quinolone Designed for Ocular Infections--Besifloxacin |
---|---|
作 者 | 許靜婷; 陳宏毅; | 書刊名 | 藥學雜誌 |
卷 期 | 27:3=108 2011.09[民100.09] |
頁 次 | 頁18-22 |
分類號 | 418.2323 |
關鍵詞 | 細菌性結膜炎; Besifloxacin; |
語 文 | 中文(Chinese) |
中文摘要 | 細菌性結膜炎 (bacterial conjunctivitis)在急性結膜炎病人中佔了極大的比例,而其發生率及致病的菌種通常跟病人的年紀和環境、衛生習慣甚至是氣候都有相關性 1。在美國,最常造成兒童產生細菌性結膜炎的菌種是 Haemophilus influenza和 Streptococcus pneumoniae;而在成人身上,常見的菌種則是 H. influenza和 Staphylococcus aureus2。細菌性結膜炎的治療通常會使用廣效型的抗生素。 Besifloxacin是第一個針對眼部抗菌研發的抗生素,也是目前唯一一個 FDA核准只用於結膜炎,而非用於全身性使用的 quinolone類抗生素。 |
英文摘要 | Bacterial conjunctivitis is responsible for a large proportion of acute conjunctivitis. The incidence of acute bacterial conjunctivitis and the species of infecting organism varies according to patient's age and the environmental conditions, such as hygiene practice and the climate1. In the US, Haemophilus influenzae and Streptococcus pneumoniae are the most common causes of bacterial conjunctivitis in children. H. influenzae and Staphylococcus aureus are the most common causes in adult2. Bacterial conjunctivitis is usually treated with novel antibacterial agents. Besifloxacin is the first approved antibiotic by the FDA for topical used only in the treatment of bacterial conjunctivitis. |
本系統中英文摘要資訊取自各篇刊載內容。